This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Research
Majid Karimi
Tehran University of Medical Sciences
Corresponding Author
ORCiD: https://orcid.org/0000-0003-3942-7848
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: Idiopathic male infertility (IMI) affects nearly 30 to 45% of men in their optimal reproductive age. In this regard, there are no evidence-based medications prescribed empirically to treat IMI. However, applying traditional medicine for the treatment of male infertility has attracted more attention in recent years. In the current study, the effects of date palm pollen (DPP) on sperm parameters in patients with idiopathic infertility were evaluated and compared to pentoxifylline (PTX).
Materials and methods: This study was performed on 80 adult male individuals (20-35 years old) who had oligozoospermia and/or asthenozoospermia and/or teratozoospermia. Patients received 6g DPP powder or 400 mg PTX tablets daily for three months in two separated groups (each in 40). Various sperm parameters and levels of sex hormones were measured.
Results: Compared to the PTX group, results revealed a significant improvement in sperm counts (p=0.016), morphology (p=0.029), total motility (p=0.018), progressive motility (p=0.016) and reduction of immotile sperms (p=0.014) in patients who received DPP treatment.
Conclusion Iranian Traditional Medicine (ITM) strongly recommended DPP as a therapeutic agent to cure IMI through improvement in the functional competence of sperm and semen parameters.
Keywords
Date Palm Pollen, Idiopathic Male Infertility, Pentoxifylline, Sperm Abnormality
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 12 Mar, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Sexual & Reproductive Medicine
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research
Majid Karimi
Tehran University of Medical Sciences
Corresponding Author
ORCiD: https://orcid.org/0000-0003-3942-7848
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 12 Mar, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Sexual & Reproductive Medicine
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: Idiopathic male infertility (IMI) affects nearly 30 to 45% of men in their optimal reproductive age. In this regard, there are no evidence-based medications prescribed empirically to treat IMI. However, applying traditional medicine for the treatment of male infertility has attracted more attention in recent years. In the current study, the effects of date palm pollen (DPP) on sperm parameters in patients with idiopathic infertility were evaluated and compared to pentoxifylline (PTX).
Materials and methods: This study was performed on 80 adult male individuals (20-35 years old) who had oligozoospermia and/or asthenozoospermia and/or teratozoospermia. Patients received 6g DPP powder or 400 mg PTX tablets daily for three months in two separated groups (each in 40). Various sperm parameters and levels of sex hormones were measured.
Results: Compared to the PTX group, results revealed a significant improvement in sperm counts (p=0.016), morphology (p=0.029), total motility (p=0.018), progressive motility (p=0.016) and reduction of immotile sperms (p=0.014) in patients who received DPP treatment.
Conclusion Iranian Traditional Medicine (ITM) strongly recommended DPP as a therapeutic agent to cure IMI through improvement in the functional competence of sperm and semen parameters.
This is a list of supplementary files associated with this preprint. Click to download.
Loading...